Muscle wasting and impaired muscle regeneration in a murine model of chronic pulmonary inflammation.

Muscle wasting and increased circulating levels of inflammatory cytokines, including TNF-alpha, are common features of chronic obstructive pulmonary disease. To investigate whether inflammation of the lung is responsible for systemic inflammation and muscle wasting, we adopted a mouse model of pulmonary inflammation resulting from directed overexpression of a TNF-alpha transgene controlled by the surfactant protein C (SP-C) promoter. Compared with wild-type mice, SP-C/TNF-alpha mice exhibited increased levels of TNF-alpha in the circulation and increased endogenous TNF-alpha expression in skeletal muscle, potentially reflecting an amplificatory response to circulating TNF-alpha. Decreased muscle and body weights observed in SP-C/TNF-alpha mice were indicative of muscle wasting. Further evaluation of the SP-C/TNF-alpha mouse musculature revealed a decreased muscle regenerative capacity, shown by attenuated myoblast proliferation and differentiation in response to reloading of disuse-atrophied muscle, which may contribute to skeletal muscle wasting. Importantly, incubation of cultured myoblasts with TNF-alpha also resulted in elevated TNF-alpha mRNA levels and inhibition of myoblast differentiation. Collectively, our results demonstrate that chronic pulmonary inflammation results in muscle wasting and impaired muscle regeneration in SP-C/TNF-alpha mice, possibly as a consequence of an amplificatory TNF-alpha expression circuit extending from the lung to skeletal muscle.

[1]  P. Bulpa,et al.  Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease , 2007, European Respiratory Journal.

[2]  J. Bates,et al.  Tumor Necrosis Factor–α Overexpression in Lung Disease , 2005 .

[3]  J. Bates,et al.  Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype. , 2005, American journal of respiratory and critical care medicine.

[4]  A. Ionescu,et al.  Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. , 2004, American journal of respiratory and critical care medicine.

[5]  Susan C Kandarian,et al.  Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy. , 2004, The Journal of clinical investigation.

[6]  W. Frontera,et al.  IKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice , 2004, Cell.

[7]  E. Wouters,et al.  Tumor necrosis factor‐alpha inhibits myogenic differentiation through MyoD protein destabilization , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  W. Frontera,et al.  IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. , 2004, Cell.

[9]  D. Glass,et al.  Molecular mechanisms modulating muscle mass. , 2003, Trends in molecular medicine.

[10]  D. Freyssenet,et al.  Myogenic and nonmyogenic cells differentially express proteinases, Hsc/Hsp70, and BAG-1 during skeletal muscle regeneration. , 2003, American journal of physiology. Endocrinology and metabolism.

[11]  E. Wouters,et al.  Enhanced myogenic differentiation by extracellular matrix is regulated at the early stages of myogenesis , 2003, In Vitro Cellular & Developmental Biology - Animal.

[12]  E. Senba,et al.  In Vivo Activation of STAT3 Signaling in Satellite Cells and Myofibers in Regenerating Rat Skeletal Muscles , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[13]  A. Goldberg,et al.  Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  G. Pavlath,et al.  A muscle precursor cell-dependent pathway contributes to muscle growth after atrophy. , 2001, American journal of physiology. Cell physiology.

[15]  D J Glass,et al.  Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.

[16]  A. Ionescu,et al.  Inflammatory response and body composition in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[17]  T. Hawke,et al.  Myogenic satellite cells: physiology to molecular biology. , 2001, Journal of applied physiology.

[18]  E. Wouters,et al.  Inflammatory Cytokines Inhibit Myogenic Differentiation through Activation of Nuclear Factor-␬b , 2022 .

[19]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[20]  M. Fujita,et al.  Overexpression of tumor necrosis factor-alpha produces an increase in lung volumes and pulmonary hypertension. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[21]  E. Wouters,et al.  Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-kappaB. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  C. Y. Wang,et al.  NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. , 2000, Science.

[23]  R. de Waal Malefyt,et al.  Cytokines and chemokines are both expressed by human myoblasts: possible relevance for the immune pathogenesis of muscle inflammation. , 2000, International immunology.

[24]  H. Saito,et al.  The Relationship between Chronic Hypoxemia and Activation of the Tumor Necrosis Factor- α System in Patients with Chronic Obstructive Pulmonary Disease , 2000 .

[25]  M. H. Snow,et al.  Activity‐induced fiber regeneration in rat soleus muscle , 2000, The Anatomical record.

[26]  H. Saito,et al.  The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[27]  V. Edgerton,et al.  Myonuclear domains in muscle adaptation and disease , 1999, Muscle & nerve.

[28]  Chris Albanese,et al.  NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.

[29]  H. Pahl,et al.  Activators and target genes of Rel/NF-kappaB transcription factors. , 1999, Oncogene.

[30]  E. Wouters,et al.  Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[31]  A. Goldberg,et al.  Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the N-end rule pathway. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Schwartz,et al.  Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor α , 1998 .

[33]  R. Schwartz,et al.  Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  E. Wouters,et al.  Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. , 1996, Thorax.

[35]  T. Vary,et al.  Sepsis inhibits synthesis of myofibrillar and sarcoplasmic proteins: modulation by interleukin-1 receptor antagonist. , 1996, Shock.

[36]  M. Buck,et al.  Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. , 1996, The EMBO journal.

[37]  P. Barnes,et al.  Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. , 1996, American journal of respiratory and critical care medicine.

[38]  J. Whitsett,et al.  Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. , 1995, The Journal of clinical investigation.

[39]  J. Mege,et al.  Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.

[40]  D. Gouma,et al.  Tissue distribution and clearance of soluble murine TNF receptors in mice. , 1994, Cytokine.

[41]  J. Miller,et al.  Distinct myogenic programs of embryonic and fetal mouse muscle cells: expression of the perinatal myosin heavy chain isoform in vitro. , 1992, Developmental biology.

[42]  S. Heymsfield,et al.  Height-normalized indices of the body's fat-free mass and fat mass: potentially useful indicators of nutritional status. , 1990, The American journal of clinical nutrition.

[43]  K. Tracey,et al.  Cachectin/TNF or IL-1 alpha induces cachexia with redistribution of body proteins. , 1989, The American journal of physiology.

[44]  Torti,et al.  Tumor necrosis factor inhibits human myogenesis in vitro , 1988, Molecular and cellular biology.

[45]  J. Lough,et al.  Modulation of histone H3 variant synthesis during the myoblast-myotube transition of chicken myogenesis. , 1987, Developmental biology.